Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonidegib in Relapsed Medulloblastoma
NCT01708174Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Oct 2016
- Modality
- Allosteric Modulators
- Countries
- 13
01
Overview
A Phase 2 trial of sonidegib in medulloblastoma, sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
sonidegib
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT01708174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01708174.